Reviving Lotronex, Banning Marijuana
Re “FDA Moving to Revive Deadly Drug,” May 30: Hold the phone. We have the Food and Drug Administration reconsidering the withdrawal of Lotronex despite new evidence of life-threatening complications, while the Supreme Court has made medical marijuana (which, to my knowledge, is not life-threatening) prohibited.
What could possibly explain this? I suppose a little case of ischemic colitis just doesn’t compare with the horrific threat that the smoking of marijuana will lead to harder drugs. As if those suffering with cancer and AIDS could be any less concerned with this.
If GlaxoSmithKline were allowed to grow marijuana in its labs, it would be offered in every conceivable packaging, with full FDA approval and with the government standing first in line collecting taxes. That isn’t smoke in the air I smell, it’s money, and it’s outrageous.
Bruce Phillips
Los Angeles
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
